GlassScriptPhysician profile
Cindy K Janssen
NPI 1396895397
$7,786.04
in general payments reported to CMS, 2019-2025
51 companies · $1,313 in 2025
The $1,313 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $1,408 · 2021: $1,707 · 2022: $476 · 2023: $1,337 · 2024: $1,021 · 2025: $1,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,591 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,590.61 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,896.69 | 2019-2025 | |
| Lilly USA, LLC | $536.69 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Novo Nordisk INC | $503.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $466.74 | 2019-2025 | Rexulti |
| Pfizer INC. | $375.64 | 2019-2025 | |
| Amgen INC. | $352.73 | 2019-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $349.07 | 2019-2025 | Breztri |
| Amarin Pharma, INC. | $327.83 | 2019-2021 | |
| Allergan, INC. | $300.93 | 2019-2020 | |
| Antares Pharma, INC. | $222.19 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $178.87 | 2022-2025 | |
| Glaxosmithkline, LLC. | $164.52 | 2020-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Lundbeck LLC | $157.56 | 2020-2025 | Rexulti |
| Organon LLC | $152.93 | 2022-2025 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $127.20 | 2019-2025 | Trintellix |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Janssen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.